Dr. Vikas Gupta Appointed as Managing Director & CEO of Novartis India Limited (NIL)

Dr. Vikas Gupta Appointed as Managing Director & CEO of Novartis India Limited (NIL)

Dr. Vikas Gupta has been appointed as Managing Director & Chief Executive Officer of Novartis India Limited (NIL), marking an important leadership milestone in his accomplished career in the pharmaceutical industry. Effective 29 July 2026, Novartis India Limited (NIL) is part of the ChrysCapital Group, beginning a new chapter in the company's journey.

In his new role, Dr. Gupta will lead the organization's strategic direction while building on its longstanding legacy of serving healthcare professionals and patients. His focus includes preserving the company's core values, expanding its portfolio, strengthening stakeholder relationships, fostering a people-first culture, and creating sustainable long-term value.

Prior to joining Novartis India Limited (NIL) as Managing Director & CEO, Dr. Gupta held leadership positions at Alkem Laboratories Ltd., Cipla, Glenmark Pharmaceuticals, and Ranbaxy Laboratories, where he developed deep expertise in business leadership, commercial strategy, sales, marketing, and pharmaceutical operations. He began his professional career at GTB Hospital, laying the foundation for a distinguished leadership journey spanning the healthcare and pharmaceutical sectors.

Recognized for his strategic vision and business leadership, Dr. Gupta brings extensive experience in driving organizational growth, strengthening commercial excellence, and building high-performing teams. His appointment reflects Novartis India Limited's commitment to building on its strong legacy while advancing its next phase of growth under the ChrysCapital Group.